Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07269262 · ClinicalTrials.gov registry record · NA
SUPPORT-T in Patients With Progressive Pulmonary Fibrosis and Their Caregivers
A NA study of Interstitial Lung Disease and Progressive Pulmonary Fibrosis, sponsored by Medical University of South Carolina.
- Recruiting
- Registry status
- NA
- Development phase
- 170
- Enrollment target
- 1
- Study location
NCT07269262: Recruiting NA study of Interstitial Lung Disease and Progressive Pulmonary Fibrosis, sponsored by Medical University of South Carolina.
NCT07269262 is a NA study of Interstitial Lung Disease and Progressive Pulmonary Fibrosis that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 170 participants, below the 562-participant average among 36 other Interstitial Lung Disease trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07269262, a NA study of Interstitial Lung Disease and Progressive Pulmonary Fibrosis, is actively recruiting participants, sponsored by Medical University of South Carolina.
- RECRUITING
- Registry status
- NA
- Development phase
- 170 participants
- Enrollment target
- 1
- Study location
Study Summary
This pilot randomized controlled trial evaluates the feasibility, acceptability, and accessibility of SUPPORT-T, a digitally delivered palliative care intervention for patients with Progressive Pulmonary Fibrosis (PPF) and their caregivers. The intervention includes a 9-week digital application guided by a nurse interventionist and quarterly virtual support groups over one year. Participants will be recruited from rural South Carolina and urban New York City. The study compares SUPPORT-T to Enhanced Usual Care and aims to inform a future multi-site trial.
Primary Outcome
Feasibility outcomes include number of participants recruited weekly, number of participants who declined, and number of participants who did not meet eligibility requirements, data collection procedures, and participant responses. Feasibility data will inform future studies on approaches for recruitment and retention, study procedures, and timing and participant capacity to complete surveys/interviews.
Conditions Studied
Interventions
- OTHER SUPPORT-T Educational Intervention
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2026-01-13 |
| Est. Completion | 2027-10-01 |
| Phase | NA |
What NCT07269262 shows while recruiting
NCT07269262 is an interventional study that assigns participants to a tested intervention. The registered 170 participants enrollment target is mid-sized for trials with a published cap, below the 562-participant average among 36 other Interstitial Lung Disease trials with a reported enrollment target (70% lower).
The record links to 2 conditions, with Interstitial Lung Disease appearing as the primary indexed condition, and to 1 intervention - of which SUPPORT-T Educational Intervention is the first listed.
NCT07269262 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT07269262 about?
NCT07269262 is a clinical study titled "SUPPORT-T in Patients With Progressive Pulmonary Fibrosis and Their Caregivers". This pilot randomized controlled trial evaluates the feasibility, acceptability, and accessibility of SUPPORT-T, a digitally delivered palliative care intervention for patients with Progressive Pulmonary Fibrosis (PPF) and their caregivers. The intervention includes a 9-week digital application guid...
What is the current status of trial NCT07269262?
This trial is currently recruiting. It is a NA study. The enrollment target is 170 participants. The study started on 2026-01-13. Estimated completion is 2027-10-01.
What conditions does trial NCT07269262 study?
This clinical trial studies the following conditions: Interstitial Lung Disease, Progressive Pulmonary Fibrosis.
What interventions are being tested in trial NCT07269262?
The interventions under investigation include: SUPPORT-T Educational Intervention (OTHER).
Who is sponsoring clinical trial NCT07269262?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07269262 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Interstitial Lung Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07269262's enrollment target sits among peer trials
170 16th of 36 higher than 21 of 36 other Interstitial Lung Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Interstitial Lung Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Telehealth and Onsite Maintenance Exercise in Chronic Lung Disease
RECRUITING · NA
-
Palliative Care Planner (PCplanner)
COMPLETED · NA
-
Comparison of Transbronchial, Cryoprobe and VATS Biopsy For the Diagnosis of Interstitial Lung Disease (ILD)
COMPLETED · NA
-
Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection
RECRUITING
-
Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease
RECRUITING · Phase 2
-
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02016430 · 170 participants · NA
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
- NCT02621021 · 170 participants · Phase 2
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
- NCT04094701 · 170 participants · NA
Hip Arthroscopy Postoperative Opioid Demands
- NCT04166409 · 170 participants · Phase 3
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI